Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1,950
Closed -$42.6K – 1171
2024
Q1
$42.6K Sell
1,950
-200
-9% -$4.29K ﹤0.01% 921
2023
Q4
$50K Hold
2,150
– – ﹤0.01% 869
2023
Q3
$42.4K Hold
2,150
– – ﹤0.01% 901
2023
Q2
$48.7K Hold
2,150
– – ﹤0.01% 893
2023
Q1
$42.2K Sell
2,150
-2,641
-55% -$50.7K ﹤0.01% 941
2022
Q4
$82.4K Buy
+4,791
New +$85K ﹤0.01% 861

Other funds holding RXO

First Manhattan's RXO Position: Q2 2024 in Review

First Manhattan sold out of RXO (RXO) in Q2 2024, closing a stake of 1,950 shares — an estimated $42.6K sold.

First Manhattan first reported a position in RXO in Q4 2022 and held it in 6 quarters. The position peaked at $82.4K in Q4 2022. 243 funds tracked by Wall St. Rank hold RXO as of Q2 2024.

  • First Manhattan reported no remaining RXO position as of Q2 2024 after selling out during the quarter.
  • First Manhattan sold 1,950 RXO shares in Q2 2024, an estimated $42.6K.
  • First Manhattan first reported a position in RXO in Q4 2022 and held it in 6 quarters.
  • First Manhattan's RXO position peaked at $82.4K in Q4 2022.
  • 243 funds tracked by Wall St. Rank held RXO as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.